title: The reprogramming therapy for a patient with advanced hepatocellular carcinoma by using human-induced pluripotent stem (iPS) cells technology.
abstract: Therapeutic methods to reprogramme and destroy human solid tumour cells have not been developed. We show a proof-of-concept for the direct reprogramming therapy of human solid tumour cells. Furthermore, our study is the first to report on the development of a new treatment by using human-induced pluripotent stem cells technology.
authors: Reprogramming Inc., Chiba, Japan. moriguchi-tky@umin.ac.jp
authors: Hisashi
authors: H
authors: Moriguchi
authors: Joren
authors: J
authors: Madson
references: Hepatology. 2010 Mar;51(3):1090-1
references: 20041407
references: N Engl J Med. 1996 Mar 14;334(11):693-9
references: 8594428
references: Liver Int. 2008 Mar;28(3):347-54
references: 18290777
references: World J Surg Oncol. 2012 Feb 17;10:41
references: 22339891
references: N Engl J Med. 2008 Jul 24;359(4):378-90
references: 18650514
references: Lancet Oncol. 2009 Jan;10(1):35-43
references: 19058754
references: Science. 1956 Aug 10;124(3215):269-70
references: 13351639